Real-world study of dabigatran etexilate for thromboprophy-laxis in over 5000 hip or knee replacement patients: favourable safety profile in subgroups with different BMI, renal function and age. Blood (ASH Annual Meeting Abstracts) - Rosencher, N (2012)
Abstract 1160.